NeuroOne Medical Technolo... (NMTC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
NeuroOne Medical Technologies Corporation operates as a medical technology company.
The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.
It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode.
The company is based in Eden Prairie, Minnesota.
Country | United States |
IPO Date | Mar 15, 2018 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 16 |
CEO | David A. Rosa M.D. |
Contact Details
Address: 7599 Anagram Drive Eden Prairie, Minnesota United States | |
Website | https://n1mtc.com |
Stock Details
Ticker Symbol | NMTC |
Exchange | NASDAQ |
Fiscal Year | October - September |
Reporting Currency | USD |
CIK Code | 0001500198 |
CUSIP Number | 64130M209 |
ISIN Number | US64130M2098 |
Employer ID | 27-0863354 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
David A. Rosa M.D. | President, Chief Executive Officer & Director |
Christopher R. Volker CFA | Chief Operating Officer |
Ronald W. McClurg | Chief Financial Officer |
Steven Mertens | Chief Technology Officer |
Hijaz Haris | Vice President of Marketing |
Mark Christianson | Co-Founder, Business Development Director & Medical Sales Liaison |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 14, 2025 | 8-K | Current Report |
Jan 13, 2025 | PRER14A | Filing |
Jan 10, 2025 | 8-K | Current Report |
Jan 10, 2025 | PRE 14A | Filing |
Jan 10, 2025 | 8-K | Current Report |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Dec 17, 2024 | 8-K | Current Report |
Dec 17, 2024 | 10-K | Annual Report |